Recurrent herpes labialis and Herpes simplex virus-1 genitalis: what is the link?


Journal

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia
ISSN: 1827-1820
Titre abrégé: G Ital Dermatol Venereol
Pays: Italy
ID NLM: 8102852

Informations de publication

Date de publication:
Oct 2019
Historique:
pubmed: 10 2 2017
medline: 1 4 2020
entrez: 10 2 2017
Statut: ppublish

Résumé

Recently, Herpes simplex virus (HSV)-1 seroprevalence declined among adolescents, rendering young people lacking HSV-1 antibodies more susceptible to genital HSV-1 acquisition, if sexually exposed. The aim of the present study was to identify the possible risk factors for the development of HSV-1 related Herpes genitalis (HG). From January 2012 to December 2015, patients with HG attending three Sexually Transmitted Infections Units in Northern Italy were recruited. A genital swab on the lesions for the search of HSV-1/2 DNA through real time polymerase chain reaction (PCR) and a serum sample for HSV-1/2 specific serology were performed. Moreover, patients were asked whether they had personal history of herpes labialis (HL). Patients with PCR proved HSV-1 HG were included as cases; asymptomatic subjects attending STI Units for a blood check were recruited as controls and were checked for HSV-1/2 serology. The study included 141 cases and 70 controls. Specific HSV-1 antibodies were found in 34.7% of the cases and 67% of the controls. History of recurrent herpes labialis (RHL) was found in 4% of the cases and 31% of the controls. The occurrence of RHL in HSV-1 seropositive patients resulted lower in the case group compared to the control group. We can speculate about a protective role for RHL against the clinical appearance of HSV-1 HG. The clinical usefulness of our study involved especially the counselling in serodiscordant couples. The presence of HSV-1 antibodies in asymptomatic sexual partners does appear protective for HG manifestation only in presence of RHL history.

Sections du résumé

BACKGROUND BACKGROUND
Recently, Herpes simplex virus (HSV)-1 seroprevalence declined among adolescents, rendering young people lacking HSV-1 antibodies more susceptible to genital HSV-1 acquisition, if sexually exposed. The aim of the present study was to identify the possible risk factors for the development of HSV-1 related Herpes genitalis (HG).
METHODS METHODS
From January 2012 to December 2015, patients with HG attending three Sexually Transmitted Infections Units in Northern Italy were recruited. A genital swab on the lesions for the search of HSV-1/2 DNA through real time polymerase chain reaction (PCR) and a serum sample for HSV-1/2 specific serology were performed. Moreover, patients were asked whether they had personal history of herpes labialis (HL). Patients with PCR proved HSV-1 HG were included as cases; asymptomatic subjects attending STI Units for a blood check were recruited as controls and were checked for HSV-1/2 serology.
RESULTS RESULTS
The study included 141 cases and 70 controls. Specific HSV-1 antibodies were found in 34.7% of the cases and 67% of the controls. History of recurrent herpes labialis (RHL) was found in 4% of the cases and 31% of the controls. The occurrence of RHL in HSV-1 seropositive patients resulted lower in the case group compared to the control group.
CONCLUSIONS CONCLUSIONS
We can speculate about a protective role for RHL against the clinical appearance of HSV-1 HG. The clinical usefulness of our study involved especially the counselling in serodiscordant couples. The presence of HSV-1 antibodies in asymptomatic sexual partners does appear protective for HG manifestation only in presence of RHL history.

Identifiants

pubmed: 28181784
pii: S0392-0488.17.05563-8
doi: 10.23736/S0392-0488.17.05563-8
doi:

Substances chimiques

Antibodies, Viral 0
DNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

529-532

Auteurs

Sergio Delmonte (S)

Unit of Dermatology, Department of Medical Sciences, Center of Genital Dermatology and Sexually Transmitted Infections, University of Turin, Turin, Italy.

Francesca Sidoti (F)

Unit of Microbiology and Virology, Laboratory of Virology, Città della Salute e della Scienza, Turin, Italy.
Department of Public Health and Pediatrics, University of Turin, Turin, Italy.

Simone Ribero (S)

Unit of Dermatology, Department of Medical Sciences, Center of Genital Dermatology and Sexually Transmitted Infections, University of Turin, Turin, Italy.
Section of Dermatology, Department of Medical Sciences, University of Turin, Turin, Italy.

Ivano Dal Conte (I)

Section of Dermatology, Department of Medical Sciences, University of Turin, Turin, Italy.

Antonio Curtoni (A)

Unit of Microbiology and Virology, Laboratory of Virology, Città della Salute e della Scienza, Turin, Italy.
Department of Public Health and Pediatrics, University of Turin, Turin, Italy.

Giulia Ciccarese (G)

Section of Dermatology, Department of Health Sciences, San Martino University Hospital IRCCS, University of Genoa, Genoa, Italy - giuliaciccarese@libero.it.

Elena Stroppiana (E)

Unit of Dermatology, Department of Medical Sciences, Center of Genital Dermatology and Sexually Transmitted Infections, University of Turin, Turin, Italy.

Maria L Stella (ML)

Department of Infectious Diseases, Sexually Transmitted Infections Clinic, Amedeo di Savoia Hospital, Turin, Italy.

Cristina Costa (C)

Unit of Microbiology and Virology, Laboratory of Virology, Città della Salute e della Scienza, Turin, Italy.
Department of Public Health and Pediatrics, University of Turin, Turin, Italy.

Rossana Cavallo (R)

Unit of Microbiology and Virology, Laboratory of Virology, Città della Salute e della Scienza, Turin, Italy.
Department of Public Health and Pediatrics, University of Turin, Turin, Italy.

Alfredo Rebora (A)

Section of Dermatology, Department of Health Sciences, San Martino University Hospital IRCCS, University of Genoa, Genoa, Italy.

Francesco Drago (F)

Section of Dermatology, Department of Health Sciences, San Martino University Hospital IRCCS, University of Genoa, Genoa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH